Loading...
XSHE002562
Market cap589mUSD
Jan 10, Last price  
4.06CNY
1D
-2.40%
1Q
11.54%
Jan 2017
-46.23%
IPO
-7.20%
Name

Brother Enterprises Holding Co Ltd

Chart & Performance

D1W1MN
XSHE:002562 chart
P/E
—
P/S
1.53
EPS
—
Div Yield, %
4.23%
Shrs. gr., 5y
7.25%
Rev. gr., 5y
14.80%
Revenues
2.82b
-17.30%
596,811,400530,399,244596,939,980620,701,193775,006,213784,216,381800,923,038905,290,7221,063,397,4481,564,526,7991,415,016,6891,257,717,1081,918,791,9692,732,994,0493,411,357,9242,821,165,745
Net income
-175m
L
37,234,59941,379,00450,470,70651,097,407018,428,79440,033,66782,244,476167,668,355403,042,72121,817,26343,825,50628,028,82028,332,607305,551,662-175,468,814
CFO
49m
-67.42%
81,232,45960,824,64350,266,9810149,135,156120,874,25991,415,751227,429,742118,636,102123,128,954293,094,049000150,996,63049,198,654
Dividend
May 10, 20230.1 CNY/sh
Earnings
May 21, 2025

Profile

Brother Enterprises Holding Co.,Ltd. engages in the production and sale of leather chemicals in China and internationally. It operates in four divisions: Leather Chemicals, Vitamins, Spices, and Active Pharmaceutical Ingredients. The company offers vitamin nutritional additives, including vitamin K3, vitamin B1, nicotinamide, niacin, vitamin B5, and alanine; leather chemicals, such as chrome tanning agents, retanning agents, fatliquors, additives, etc.; and active pharmaceutical ingredients (API) comprising contrast agent APIs, topiroxostat, and the custom-made APIs and intermediates for endocrine and metabolism, nerves, respiratory and other therapeutic areas. It also provides flavors and fragrances, which include vanillin, ethyl vanillin, and other synthetic fragrances, as well as turpentine for food, daily chemical, and other industries; molecular sieves and catalysts; and sodium dichromate, chromic acid, and chrome tanning agent. The company was formerly known as Haining Leather Chemicals Factory. Brother Enterprises Holding Co.,Ltd. was founded in 1991 and is headquartered in Haining, China.
URL
http://www.brother.com.cn/
IPO date
Mar 10, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,821,166
-17.30%
3,411,358
24.82%
Cost of revenue
2,762,033
2,850,246
Unusual Expense (Income)
NOPBT
59,133
561,112
NOPBT Margin
2.10%
16.45%
Operating Taxes
16,645
70,455
Tax Rate
28.15%
12.56%
NOPAT
42,488
490,656
Net income
(175,469)
-157.43%
305,552
978.45%
Dividends
(182,681)
Dividend yield
4.38%
Proceeds from repurchase of equity
29,610
BB yield
-0.56%
Debt
Debt current
1,518,758
825,874
Long-term debt
146,724
532,176
Deferred revenue
43,797
32,871
Other long-term liabilities
78,984
35,885
Net debt
1,291,743
900,938
Cash flow
Cash from operating activities
49,199
150,997
CAPEX
(368,091)
Cash from investing activities
(127,004)
Cash from financing activities
122,938
FCF
(105,426)
42,517
Balance
Cash
365,428
457,112
Long term investments
8,310
Excess cash
232,680
286,544
Stockholders' equity
1,662,789
2,070,807
Invested Capital
4,563,161
4,493,021
ROIC
0.94%
11.56%
ROCE
1.22%
11.65%
EV
Common stock shares outstanding
1,032,169
1,131,576
Price
4.04
-14.04%
4.70
-5.81%
Market cap
4,169,965
-21.59%
5,318,409
12.85%
EV
5,461,708
6,219,347
EBITDA
386,821
872,859
EV/EBITDA
14.12
7.13
Interest
77,154
54,012
Interest/NOPBT
130.48%
9.63%